TuHURA Biosciences (HURA) Capital Expenditures (2022 - 2026)
TuHURA Biosciences' (HURA) quarterly Capital Expenditures came in at $48846.0 in Q1 2026, up 168.21% year-on-year from $18211.9 in Q1 2025, and up 126.32% quarter-over-quarter from -$185574.0 in Q4 2025.
TuHURA Biosciences (HURA) Capital Expenditures (2022 - 2026) Analysis & Trends
TuHURA Biosciences' Capital Expenditures history runs 5 years deep, the most recent figure standing at $48846.0 for Q1 2026.
- On a quarterly basis, Capital Expenditures rose 168.21% year-over-year to $48846.0 in Q1 2026; TTM through Mar 2026 was -$34540.0, a 167.64% decrease from a year earlier, with the FY2025 full-year figure at -$154998.0, down 45.38% from the prior year.
- Capital Expenditures grew to $48846.0 in Q1 2026 per HURA's latest filing, from -$185574.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $232000.0 in Q3 2022 and bottomed at -$185574.0 in Q4 2025.
- The 5-year median for Capital Expenditures is $34423.0 (2023), against an average of $26852.2.
- Biggest YoY gain for Capital Expenditures was 262.49% in 2025; the steepest drop was 226.13% in 2025.
- Year by year, Capital Expenditures stood at $232000.0 in 2022, then sank by 91.38% to $20000.0 in 2023, then surged by 666.42% to $153283.0 in 2024, then plunged by 221.07% to -$185574.0 in 2025, then jumped by 126.32% to $48846.0 in 2026.
- Per Business Quant, the three latest HURA Capital Expenditures figures stand at $48846.0 (Q1 2026), -$185574.0 (Q4 2025), and -$39804.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 43.25 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 133.40 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 230.60 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 786,000.00 |
| 10 | TuHURA Biosciences | 132.62 Mn | 132.62 Mn | - | 48,846.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 48,846.00 |
| Mar 31, 2026 | 48,846.00 |
| Dec 31, 2025 | -185,574.00 |
| Dec 31, 2025 | -185,574.00 |
| Sep 30, 2025 | -39,804.00 |
| Sep 30, 2025 | -39,804.00 |
| Jun 30, 2025 | 141,992.00 |
| Jun 30, 2025 | 141,992.00 |
| Mar 31, 2025 | -71,612.00 |
| Mar 31, 2025 | -71,612.00 |
| Sep 30, 2024 | 153,283.00 |
| Sep 30, 2024 | 153,283.00 |
| Jun 30, 2024 | -87,386.00 |
| Jun 30, 2024 | -87,386.00 |
| Mar 31, 2024 | 56,777.00 |
| Mar 31, 2024 | 56,777.00 |
| Dec 31, 2023 | 20,000.00 |
| Dec 31, 2023 | 20,000.00 |
| Sep 30, 2022 | 232,000.00 |
| Sep 30, 2022 | 232,000.00 |